Fox Chase Holds FREE Event for Lung Cancer Patients
"Together, Facing Lung Cancer" Offers Patients and Their Caregivers Support
PHILADELPHIA (November 5, 2012)—Fox Chase Cancer Center invites lung cancer patients and their caregivers to a FREE event titled “Together Facing Lung Cancer” on Monday, November 12, 2012 at 5:00 p.m. (dinner will be served at 5:00 p.m. and official program will start at 5:45 p.m.). The event, which offers support to patients and caregivers facing lung cancer, will be held in the Fox Chase Cancer Center auditorium (333 Cottman Avenue, Philadelphia).
At the event health-care professionals from Fox Chase will discuss the treatment of lung cancer, management of side effects and the importance of building a support system of friends, caregivers, health-care professionals, and counselors to help patients through their journey with lung cancer. There will also be a panel of lung cancer survivors present, as well members of the Fox Chase Lung Cancer Team to answer questions.
Registration is required, as guests will be served a free dinner. For more information or to register, please call Robin Sturm at 215-728-2580.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).